Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2

Numerous neutralizing antibodies that target SARS-CoV-2 have been reported, and most directly block binding of the viral Spike receptor-binding domain (RBD) to angiotensin-converting enzyme II (ACE2). Here, we deliberately exploit non-neutralizing RBD antibodies, showing they can dramatically assist...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Shion A., Gramespacher, Josef A., Pance, Katarina, Rettko, Nicholas J., Solomon, Paige, Jin, Jing, Lui, Irene, Elledge, Susanna K., Liu, Jia, Bracken, Colton J., Simmons, Graham, Zhou, Xin X., Leung, Kevin K., Wells, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939556/
https://www.ncbi.nlm.nih.gov/pubmed/33666135
http://dx.doi.org/10.1080/19420862.2021.1893426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939556/
https://www.ncbi.nlm.nih.gov/pubmed/33666135
http://dx.doi.org/10.1080/19420862.2021.1893426

Ejemplares similares